Loading organizations...
§ Private Profile · Knoxville, TN, USA
Manufacturer of compact, automated cyclotron systems producing radiopharmaceuticals for on-site PET scan diagnostics in hospitals.
ABT Molecular Imaging is a Louisville, Tennessee-based medical technology company that develops and manufactures compact, automated cyclotron systems for the on-site production of molecular imaging drugs used in PET scanning. The organization provides hospitals and clinical research institutions with capital equipment, specifically the BG-75 Biomarker Generator, alongside single-use consumable chemistry kits to synthesize single doses of radiopharmaceuticals on demand. Prior to its strategic exit, the enterprise secured two federal grants through Small Business Innovation Research awards in 2015 and 2017 to advance its diagnostic imaging product line. The company was acquired in 2019 following the leadership of former CEO Peter Kingma, and now operates as a subsidiary of Best Medical International, integrating into the broader TeamBest Global Companies conglomerate led by Krishnan Suthanthiran. ABT Molecular Imaging was founded in 2006 by PET/CT co-inventor Ronald Nutt and Lynda Nutt.
ABT Molecular Imaging has raised $15.0M across 2 funding rounds.
ABT Molecular Imaging has raised $15.0M in total across 2 funding rounds.
ABT Molecular Imaging has raised $15.0M in total across 2 funding rounds.
ABT Molecular Imaging's investors include Council Capital, Intersouth Partners, Mountain Group Partners.
ABT Molecular Imaging has raised $15.0M across 2 funding rounds. Most recently, it raised $6.0M Series C in September 2012.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 13, 2012 | $6M Series C | — | Council Capital, Intersouth Partners, Mountain Group Partners | Announced |
| Oct 6, 2009 | $9M Series A | Intersouth Partners | — | Announced |